Investment
Editor's Notes: * This week's earnings reveal a clear split in consumer behavior, where steady high-end spending numbers mask a 20% housing cancellation rate driven by basic affordability constraints. The clearest sign of pressure appears in healthcare, where an unexpected number of people losing exchange coverage
Investment
Editor's Notes: * Key investment insights from last week's earnings reveal AI as a transformative productivity engine across industries, driving robust demand for advanced tech. The healthcare sector is adapting to cost pressures and GLP-1 drug impacts, shifting towards value-based care. Industrial and logistics sectors
Investment
Editor's Notes * The reality that autonomous AI models can now find and exploit software vulnerabilities in minutes means corporate defense windows have shrunk to almost nothing. When you pair this threat with the massive build-out of ultra-fast optical networks by companies like Ciena and Credo, a
Investment
This analysis of late May 2026 earnings reports reveals six key investment themes: the rise of Agentic AI, accelerated data center build-out, enterprise IT modernization, evolving China market dynamics, consumer discretionary headwinds, and persistent macro challenges. These forward-looking insights highlight non-consensus views and critical debates impacting multiple
Investment
Editor's Notes * AI has transitioned from a capital-heavy infrastructure trade into a tactical tool for immediate margin defense. While high-speed hardware pipelines remain large, non-tech companies are quietly using software automation to optimize markdowns, streamline labor, and absorb sticky inflationary costs without expanding human headcount.
Investment
Editor's Notes * The biggest question hanging over this earnings cycle is whether the massive wave of AI spending is a structural leap or a temporary bubble. Tech and semiconductor companies are committing historic amounts of cash to infrastructure, but the street is starting to demand proof that these
Investment
Editor's Notes: * One interesting idea from the recent earnings is the (mis)pricing of big pharma patent cliffs right now. Take Bristol-Myers Squibb as an example. The market is so terrified of its impending 2028 exclusivity cliff for blockbusters like Opdivo and Eliquis that it has punished
Investment
Editor's Notes * Because we are right in the thick of heavy earnings season, we are releasing this mid-week recap to help you cut through the noise and size up the structural shifts happening in real-time. * This briefing offers professional investors concise takeaways from the latest earnings
Investment
Editor's Notes: * This week's prints expose a two-speed economy. Premium, experience-driven demand is now completely detached from the rate-sensitive, entry-level buyer getting crushed by inflation, a dynamic perfectly illustrated by American Airlines' record premium unit revenues and Shimano's massive
Investment
Editor's Notes * The first annual profit drop at BYD since 2021 is a loud signal that the domestic Chinese price war has reached a brutal knockout stage. While record sales volume continues to impress, the real story is the strategic shift to overseas markets where margins are actually
Investment
Editor's Notes: This is the second part of the earnings summary for last week — I shared part 1 yesterday. * The biggest shift that stands out is how Chinese EV players are finally crossing into profitability, but in a very different way than before. It’s less about selling
Investment
Editor's Notes: * This is part 1 of our earnings recap from the past week. We’ll share part 2 tomorrow given just how packed the calendar has been. One thing that stands out right away: AI is no longer a side narrative, it’s embedded everywhere, but the